Identification of virulence determinants activators in prokaryotic pathogens
Abstract
Disclosed is a method for identifying activators of a transition metal-dependent repressor of virulence gene expression in infectious prokaryotic pathogens. The method utilizes genetic circuitry that represents the response of a given prokaryote to nutritional stress and the expression of genes that contribute to the establishment of the infectious process. The exposure of recombinant cells or a cell-free system containing the genetic circuitry to a non-metal ion test substance that activates the repressor produces a detectable response. The method is applicable for any prokaryote employing metal ion-dependent repressors to regulate specific gene expression, specifically as it pertains to virulence determinant expression.
Claims
exact text as granted — not AI-modified1 - 17 . (canceled).
18 . A composition of matter, comprising: a recombinant vector comprising a first DNA segment containing a first promoter operably linked to a first regulatory gene encoding a first repressor native to or functional in a given procaryote, and a second DNA segment containing a second promoter operably linked to a first operator that binds said first repressor, and a second regulatory gene encoding a second repressor.
19 . The composition of matter of claim 18 wherein said recombinant vector further comprises a third DNA segment comprising a third promoter operably linked to a second operator that binds the second repressor, and a reporter gene.
20 . The composition of matter of claim 18 wherein said recombinant vector is a first recombinant vector and said composition further comprises a second recombinant vector comprising a third DNA segment comprising a third promoter operably linked to a second operator that binds the second repressor, and a reporter gene.
21 - 22 . (canceled)
23 . A composition of matter comprising: (a) purified repressor protein native to or functional in a given procaryote, a, (b) a DNA construct comprising in operable association, a promoter, an operator that binds said repressor protein and a reporter gene, (c) a transcriptional and translational system that allows expression of said reporter gene and (d) a chelating agent that binds metal ion activators of said repressor protein.
24 . The composition of matter of claim 23 further comprising a non-metal ion test substance.
25 . The composition of matter of claim 23 wherein said system comprises bacterial extract.
26 . The composition of claim 18 wherein said first regulatory gene encodes a diphtheria tox repressor (DtxR) protein.
27 . The composition of claim 18 wherein said first regulatory gene encodes DtxR and said first operator comprises native tox operator, a functional fragment of said operator or a variant of a DtxR consensus binding sequence.
28 . The composition of claim 18 wherein said first regulatory gene encodes a diphtheria tox repressor (DtxR) homologue.
29 . The composition of claim 18 wherein said DtxR homologue is an iron dependent regulator (IdeR).
30 . The composition of claim 18 wherein said first regulatory gene encodes ferric uptake regulator (Fur).
31 . The composition of claim 18 wherein said second regulatory gene encodes TetR.
32 . The composition of claim 19 wherein said second regulatory gene encodes TetR and said second operator comprises tetO.
33 . The composition of claim 19 wherein said reporter gene encodes chloramphenicol acetyltransferase.
34 . The composition of claim 20 wherein said second vector is a lambda phage.
35 . The composition of claim 19 , wherein said first regulatory gene encodes a diptheria tox repressor (DTXR) protein or a homologue thereof, said first operator binds said DtxR protein or homologue, said second regulatory gene encodes TetR, said second operator comprises tetO, and said reporter gene encodes chloramphenicol acetyltransferase.
36 . The composition of claim 20 , wherein said first regulatory gene encodes a diptheria tox repressor (DTXR) protein or a homologue thereof, said first operator binds said DtxR protein or homologue, said second regulatory gene encodes TetR, said second operator comprises tetO, and said reporter gene encodes chloramphenicol acetyltransferase.
37 . The composition of claim 23 wherein said chelating agent is 2,2′-dipyridyl.
38 . A recombinant host cell comprising the composition of matter of claim 18 .
39 . The recombinant host cell of claim 36 which is an E. coli cell.
40 . A recombinant host cell comprising the composition of matter of claim 20 .
41 . The recombinant host cell of claim 38 which is a E. coli cell.
42 . A composition comprising the recombinant host cell of claim 39 and a chelating agent.
43 . A composition comprising the recombinant host cell of claim 41 and a chelating agent.Join the waitlist — get patent alerts
Track US2005058665A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.